Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF
Clinical trial NCT01641822 · COMPLETED
Trial details
- NCT number
- NCT01641822
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2015-01-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.